Polymyxin-Resistant Clinical Isolates ofEscherichiacoli
نویسندگان
چکیده
منابع مشابه
Polymyxin-resistant clinical isolates of Escherichia coli.
A surveillance study to identify patients from the community with Escherichia coli resistant to broad-spectrum cephalosporins discovered two isolates that were also resistant to polymyxin B and colistin. One isolate from a patient in the community and a second from a patient who received multiple courses of polymyxin B also possessed a CTX-M-15 enzyme. Resistance to cationic peptides in E. coli...
متن کاملUltrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa.
Upon exposure to 6,000 U of polymyxin B sulfate per ml, cells of the polymyxin-sensitive PAO 1 strain of Pseudomonas aeruginosa displayed in thin sections long projections arising from the outer membrane of the cell wall and extensive cytoplasmic degradation with accumulation of cytoplasmic membrane infoldings. Polymyxin-resistant isolates derived from the PAO 1 strain, however, grew well in th...
متن کاملPolymyxin-Resistant Acinetobacter spp. Isolates: What is Next?
hyperproduction of the chromosomal enzymes, as well as resistant strains without synergy, were disregarded. During the first period, 15 (2.1%) of 707 outpatients were carriers of Escherichia coli (14 patients) or Proteus mirabilis (1 patient) with ESBL. This percentage increased during the second period, when 17 (3.8%) of 454 outpatients were carriers of E. coli with ESBL, and again in the thir...
متن کاملCombination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii
Polymyxins are last-resort antibiotics for treating infections of Gram-negative bacteria. The recent emergence of polymyxin-resistant bacteria, however, urgently demands clinical optimisation of polymyxin use to minimise further evolution of resistance. In this study we developed a novel combination therapy using minimal concentrations of polymyxin B. After large-scale screening of Streptomyces...
متن کاملIncreased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates.
Objective: Infections caused by multidrug-resistant (MDR) Acinetobacter baumannii have become a major treatment challenge, requiring the re-introduction of polymyxins into clinical practice. Given this situation, the emergence of polymyxin B resistance is expected. Recently, increased antimicrobial susceptibility among in vitro passaging of colistin-resistant A. baumannii isolates was observed ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Antimicrobial Agents and Chemotherapy
سال: 2010
ISSN: 0066-4804,1098-6596
DOI: 10.1128/aac.01088-10